SNDX Syndax Pharmaceuticals Inc
Market Cap
1.9B
Day’s Range
52W Range
Volume (3M)
866.33K
Price-Earnings Ratio
5.18K
Revenue
126.58M
Syndax Pharmaceuticals Inc Latest News
Top Discussions
27
FEB
REPORTS
Syndax Pharmaceuticals Inc Q4 2022 earnings report is expected to be released after market open

SNDX
Syndax Pharmaceuticals Inc
27.96
-0.59
(-2.07%)

SNDX
Syndax Pharmaceuticals Inc
27.90
-0.59 (-2.07%)
About Syndax Pharmaceuticals Inc
Syndax Pharmaceuticals is a clinical-stage biopharmaceutical company that operates internationally. It works to develop therapies to treat cancer. Founded in 2005, the company has headquarters in Waltham, Massachusetts. Syndax Pharmaceuticals is listed on the NASDAQ GS stock market under the tickerSNDX. Follow SNDX share price movements with the help of your eToro watchlist.
Show More59
Employees
Waltham, Massachusetts, US
HQ
2005
Founded
Michael A. Metzger, MBA
CEO
Upcoming Earnings
27
FEB
REPORTS
Syndax Pharmaceuticals Inc Q4 2022 earnings report is expected to be released after market open
Get insight into a company's sustainability using ESG (environmental, social, and governance) scores.
0
100
48
Low
Industry
Avg. 45
32
Environment
45
Social
59
Governance
People Also Bought
- ODP The ODP Corporation -0.77%
- CNO CNO Financial Group Inc -0.12%
- AIN Albany International Corp 0.11%
- CLDX Celldex Therapeutics Inc 2.47%
- PHR Phreesia Inc -4.08%
ALSN Allison Transmission Holdings Inc 0.33%
KN Knowles Corporation -2.05%
WERN Werner Enterprises Inc. -1.46%